BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2023 ,inter alia, to consider and approve Unaudited financial results of the Company for the quarter ended 31.12.2022. Further, pursuant to amended provisions of SEBI (Prohibition of Insider Trading Regulations),2015 and as per the provisions of Code of Conduct of the Company, the trading window for dealing in securities of the Company by its designated persons/employees and their immediate relatives was closed from 01.01.2023 up to 08.02.2023 i.e 48 hours after declaration of financial results of the Company.